1. Home
  2. SSSS vs ZTEK Comparison

SSSS vs ZTEK Comparison

Compare SSSS & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSSS
  • ZTEK
  • Stock Information
  • Founded
  • SSSS 2010
  • ZTEK 2008
  • Country
  • SSSS United States
  • ZTEK Canada
  • Employees
  • SSSS N/A
  • ZTEK N/A
  • Industry
  • SSSS Finance: Consumer Services
  • ZTEK Major Chemicals
  • Sector
  • SSSS Finance
  • ZTEK Industrials
  • Exchange
  • SSSS Nasdaq
  • ZTEK Nasdaq
  • Market Cap
  • SSSS 143.5M
  • ZTEK 116.6M
  • IPO Year
  • SSSS N/A
  • ZTEK N/A
  • Fundamental
  • Price
  • SSSS $5.83
  • ZTEK $0.86
  • Analyst Decision
  • SSSS Buy
  • ZTEK
  • Analyst Count
  • SSSS 2
  • ZTEK 0
  • Target Price
  • SSSS $6.00
  • ZTEK N/A
  • AVG Volume (30 Days)
  • SSSS 245.8K
  • ZTEK 37.3K
  • Earning Date
  • SSSS 11-07-2024
  • ZTEK 02-11-2025
  • Dividend Yield
  • SSSS N/A
  • ZTEK N/A
  • EPS Growth
  • SSSS N/A
  • ZTEK N/A
  • EPS
  • SSSS N/A
  • ZTEK N/A
  • Revenue
  • SSSS $5,903,895.00
  • ZTEK $29,132.00
  • Revenue This Year
  • SSSS N/A
  • ZTEK N/A
  • Revenue Next Year
  • SSSS $6.05
  • ZTEK N/A
  • P/E Ratio
  • SSSS N/A
  • ZTEK N/A
  • Revenue Growth
  • SSSS 5.43
  • ZTEK 8.15
  • 52 Week Low
  • SSSS $3.32
  • ZTEK $0.50
  • 52 Week High
  • SSSS $6.65
  • ZTEK $1.59
  • Technical
  • Relative Strength Index (RSI)
  • SSSS 55.63
  • ZTEK 34.48
  • Support Level
  • SSSS $5.51
  • ZTEK $1.05
  • Resistance Level
  • SSSS $6.65
  • ZTEK $1.16
  • Average True Range (ATR)
  • SSSS 0.39
  • ZTEK 0.08
  • MACD
  • SSSS -0.06
  • ZTEK -0.04
  • Stochastic Oscillator
  • SSSS 39.71
  • ZTEK 8.57

About SSSS SuRo Capital Corp.

SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.

About ZTEK Zentek Ltd.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Share on Social Networks: